Why Are Children With Bronchiolitis At Risk Of Urinary Tract Infections?

References

• Vareille M, Kieninger E, Edwards MR, Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev. 2011;24(1):210–229. doi:10.1128/CMR.00014-1021233513
   PubMed Web of Science ®Google Scholar
• Walzl G, Tafuro S, Moss P, Openshaw PJ, Hussell T. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J Exp Med. 2000;192(9):1317–1326. doi:10.1084/jem.192.9.131711067880
   PubMed Web of Science ®Google Scholar
• Ralston S, Hill V, Waters A. Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: a systematic review. Arch Pediatr Adolesc Med. 2011;165:951–956. doi:10.1001/archpediatrics.2011.15521969396
   PubMedGoogle Scholar
• Melendez E, Harper MB. Utility of sepsis evaluation in infants 90 days of age or younger with fever and clinical bronchiolitis. Pediatr Infect Dis J. 2003;22:1053–1056. doi:10.1097/01.inf.0000101296.68993.4d14688564
   PubMed Web of Science ®Google Scholar
• Levine DA, Platt SL, Dayan PS, et al. Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics. 2004;113:1728–1734. doi:10.1542/peds.113.6.172815173498
   PubMed Web of Science ®Google Scholar
• Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med. 2002;156:322–324. doi:10.1001/archpedi.156.4.32211929363
   PubMedGoogle Scholar
• Titus MO, Wright SW. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection. Pediatrics 2003;112:282–284. doi:10.1542/peds.112.2.28212897274
   PubMed Web of Science ®Google Scholar
• Hendaus MA, Alhammadi AH, Khalifa MS, Muneer E, Chandra P. Risk of urinary tract infection in infants and children with acute bronchiolitis. Paediatr Child Health. 2015;20(5):e25–e29. doi:10.1093/pch/20.5.e2526175566
   PubMed Web of Science ®Google Scholar
• Oray-Schrom P, Phoenix C, St Martin D, Amoateng-Adjepong Y. Sepsis workup in febrile infants 0–90 days of age with respiratory syncytial virus infection. Pediatr Emerg Care. 2003;19:314–319. doi:10.1097/01.pec.0000092576.40174.2814578830
   PubMed Web of Science ®Google Scholar
• Byington CL, Enriquez FR, Hoff C, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics 2004;113:1662–1666. doi:10.1542/peds.113.6.166215173488
   PubMed Web of Science ®Google Scholar
• Antonow JA, Hansen K, McKinstry CA, Byington CL. Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr Infect Dis J. 1998;17:231–236. doi:10.1097/00006454-199803000-000119535251
   PubMed Web of Science ®Google Scholar
• Bilavsky E, Shouval DS, Yarden-Bilavsky H, Fisch N, Ashkenazi S, Amir J. A prospective study of the risk for serious bacterial infections in hospitalized febrile infants with or without bronchiolitis. Pediatr Infect Dis J. 2008;27:269–270. doi:10.1097/INF.0b013e31815e85b118277919
   PubMed Web of Science ®Google Scholar
• Kuppermann N, Bank DE, Walton EA, Senac MO Jr, McCaslin I. Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. Arch Pediatr Adolesc Med. 1997;151:1207–1214. doi:10.1001/archpedi.1997.021704900330069412595
   PubMedGoogle Scholar
• Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics. 1993;92:1–12.
   Web of Science ®Google Scholar
• Liebelt EL, Qi K, Harvey K. Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis. Arch Pediatr Adolesc Med. 1999;153:525–530. doi:10.1001/archpedi.153.5.52510323635
   PubMedGoogle Scholar
• Luginbuhl LM, Newman TB, Pantell RH, Finch SA, Wasserman RC. Office-based treatment and outcomes for febrile infants with clinically diagnosed bronchiolitis. Pediatrics 2008;122:947–954. doi:10.1542/peds.2007-320618977972
   PubMed Web of Science ®Google Scholar
• McDaniel CE, Ralston S, Lucas B, Schroeder AR. Association of diagnostic criteria with urinary tract infection prevalence in bronchiolitis: a systematic review and meta-analysis. JAMA Pediatr. 2019. doi:10.1001/jamapediatrics.2018.5091.
   Web of Science ®Google Scholar
• Elkhunovich MA, Wang VJ. Assessing the utility of urine testing in febrile infants aged 2 to 12months with bronchiolitis. Pediatr Emerg Care. 2015;31(9):616–620. doi:10.1097/PEC.000000000000035925834961
   PubMed Web of Science ®Google Scholar
• Purcell K, Fergie J. Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2004;23(3):267–269. doi:10.1097/01.inf.0000116759.21252.2915014307
   PubMed Web of Science ®Google Scholar
• Kaluarachchi D, Kaldas V, Roques E, Nunez R, Mendez M. Comparison of urinary tract infection rates among 2- to 12-month-old febrile infants with RSV infections using 1999 and 2011 AAP diagnostic criteria. Clin Pediatr (Phila). 2014;53(8):742–746. doi:10.1177/000992281452901524681546
   PubMed Web of Science ®Google Scholar
• Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J. 2004;23(11):990–994. doi:10.1097/01.inf.0000143647.88873.6615545852
   PubMed Web of Science ®Google Scholar
• Schlechter Salinas AK, Hains DS, Jones T, Harrell C, Meredith M. Testing for urinary tract infection in the influenza/respiratory syncytial virus-positive febrile infant aged 2 to 12 months. Pediatr Emerg Care. 2017. doi:10.1097/PEC.0000000000001073
   Web of Science ®Google Scholar
• Yarden-Bilavsky H, Ashkenazi-Hoffnung L, Livni G, Amir J, Bilavsky E. Month-by-month age analysis of the risk for serious bacterial infections in febrile infants with bronchiolitis. Clin Pediatr (Phila). 2011;50(11):1052–1056. doi:10.1177/000992281141294921685212
   PubMed Web of Science ®Google Scholar
• García CG, Bhore R, Soriano-Fallas A, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics. 2010;126(6):e1453–e1460. doi:10.1542/peds.2010-050721098154
   PubMed Web of Science ®Google Scholar
• Librizzi J, McCulloh R, Koehn K, Alverson B. Appropriateness of testing for serious bacterial infection in children hospitalized with bronchiolitis. Hosp Pediatr. 2014;4(1):33–38. doi:10.1542/hpeds.2013-007324435599
   PubMedGoogle Scholar
• Roberts KB, American Academy of Pediatrics, Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management. Urinary tract infection: clincal practice guideline for diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128:595–610.21873693
   PubMed Web of Science ®Google Scholar
• Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 2009;135(2):505–512. doi:10.1378/chest.08-041219201713
   PubMed Web of Science ®Google Scholar
• Thornton DJ, Rousseau K, McGuckin MA. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol. 2008;70:459–486. doi:10.1146/annurev.physiol.70.113006.10070217850213
   PubMed Web of Science ®Google Scholar
• Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2006;86(1):245–278. doi:10.1152/physrev.00010.200516371599
   PubMed Web of Science ®Google Scholar
• Pittet LA, Hall-Stoodley L, Rutkowski MR, Harmsen AG. Influenza virus infection decrease stracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2010;42(4):450–460. doi:10.1165/rcmb.2007-0417OC19520922
   PubMed Web of Science ®Google Scholar
• Wilson R, Dowling RB, Jackson AD. The biology of bacterial-colonization and invasion of the respiratory mucosa. Eur Respir J. 1996;9(7):1523–1530. doi:10.1183/09031936.96.090715238836669
   PubMed Web of Science ®Google Scholar
• Tristram DA, Hicks W Jr, Hard R. Respiratory syncytial virus and human bronchial epithelium. Arch Otolaryngol Head Neck Surg. 1998;124:777–783. doi:10.1001/archotol.124.7.7779677113
   PubMed Web of Science ®Google Scholar
• McCullers JA, Iverson AR, McKeon R, Murray PJ. The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scand J Infect Dis. 2008;40(1):11–17. doi:10.1080/0036554070147756817852951
   PubMed Web of Science ®Google Scholar
• Bragonzi A, Copreni E, de Bentzmann S, Ulrich M, Conese M. Airway epithelial cell-pathogen interactions. J Cyst Fibros. 2004;3(suppl 2):197–201. doi:10.1016/j.jcf.2004.05.041
   PubMedGoogle Scholar
• Katze MG, He Y, Gale M Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2(9):675–687. doi:10.1038/nri88812209136
   PubMed Web of Science ®Google Scholar
• Akira S. Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(4):143–156. doi:10.2183/pjab.85.143
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783–801. doi:10.1016/j.cell.2006.02.01516497588
   PubMed Web of Science ®Google Scholar
• Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med. 2008;205(2):323–329. doi:10.1084/jem.2007089118227219
   PubMed Web of Science ®Google Scholar
• Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007;27:549–559. doi:10.1016/j.immuni.2007.10.00217967410
   PubMed Web of Science ®Google Scholar
• Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem. 2003;278:5509–5512.12514169
   PubMed Web of Science ®Google Scholar
• Basler CF, García-Sastre A. Viruses and the type I interferon antiviral system: induction and evasion. Int Rev Immunol. 2002;21(4–5):305–337. doi:10.1080/0883018021327712486817
   PubMedGoogle Scholar
• Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol. 2004;5:975–979. doi:10.1038/ni111615454920
   PubMed Web of Science ®Google Scholar
• Message SD, Johnston SL. Host defense function of the airway epithelium in health and disease: clinical background. J Leukoc Biol. 2004;75(1):5–17. doi:10.1189/jlb.070331512972516
   PubMed Web of Science ®Google Scholar
• Ishizuka S, Yamaya M, Suzuki T, et al. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J Infect Dis. 2003;188(12):1928–1939. doi:10.1086/jid.2003.188.issue-1214673774
   PubMed Web of Science ®Google Scholar
• Nansen A, Randrup Thomsen A. Viral infection causes rapid sensitization to lipopolysaccharide: central role of IFN-alpha beta. J Immunol. 2001;166:982–988. doi:10.4049/jimmunol.166.2.98211145676
   PubMed Web of Science ®Google Scholar
• Doughty L, Nguyen K, Durbin J, Biron C. A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin. J Immunol. 2001;166:2658–2664. doi:10.4049/jimmunol.166.4.265811160329
   PubMed Web of Science ®Google Scholar
• Kim YG, Park JH, Reimer T, et al. Viral infection augments Nod1/2 signaling to potentiate lethality. Cell Host Microbe. 2011;9(6):496–507. doi:10.1016/j.chom.2011.05.00621669398
   PubMed Web of Science ®Google Scholar